Assoc. Prof. Vuslat YILMAZ

Publication Network

Published journal articles indexed by SCI, SSCI, and AHCI

Differentiating multiple sclerosis with predominant spinal cord and optic nerve involvement from other autoimmune demyelinating diseases using B cell immunophenotyping and gene expression profiling.

Yilmaz V., Karaaslan Z., Sanli E., Yuceer-Korkmaz H., Ulusoy C. A., Timirci-Kahraman Ö., et al.

Multiple sclerosis and related disorders , vol.93, no.1, pp.106238, 2024 (SCI-Expanded)

Effects of immune modulatory treatment on language and psychiatric profile in patients with electrical status epilepticus in sleep (ESES).

Emekli A. S., Dörtkol Ş. O., Savaş M., Öz F., İşcen P., Topaloğlu P., et al.

Epilepsy & behavior : E&B , vol.163, pp.110225, 2024 (SCI-Expanded)

Peripheral Blood Lymphocyte Subgroups in Patients Undergoing Hemodialysis with Medium Cutoff Membranes and High-Flux Membranes: THE SHE Continuation Study.

Hasbal N. B., Sevinc M., Yilmaz V., Yılmaz A., Yuceer Korkmaz H., Basturk T., et al.

Blood purification , vol.53, no.11-12, pp.937-946, 2024 (SCI-Expanded)

Distinctive sleep complaints and polysomnographic findings in antibody subgroups of autoimmune limbic encephalitis

Küçükali C. İ., Yılmaz V., Karadeniz D., Akyıldız U. O., İlhan Algın D., Sarıtaş A. Ş., et al.

NEUROLOGICAL SCIENCES , vol.45, no.11, pp.5429-5439, 2024 (SCI-Expanded)

Altered Cerebrospinal Fluid Neurofilament Light Chain but Not Neurogranin Levels Are Associated with Response to Ocrelizumab Treatment in Relapsing-Remitting Multiple Sclerosis: A Preliminary Study

Kızılay T., Akbayir E., Erol R., Demir A. S., Özkan Yaşargün D., Yilmaz V., et al.

European Neurology , vol.87, no.4, pp.203-210, 2024 (SCI-Expanded)

Effects of Transcranial Direct Current Stimulation on Clinical Outcomes, Calcitonin Gene-Related Peptide, and Pituitary Adenylate Cyclase-Activating Polypeptide-38 Levels in Menstrual Migraine.

Hasırcı Bayır B. R., Aksu S., Gezegen H., KARAASLAN Z., YÜCEER KORKMAZ H., Cerrahoğlu Şirin T., et al.

Neuromodulation : journal of the International Neuromodulation Society , vol.27, no.5, pp.835-846, 2024 (SCI-Expanded)

The Association Between Serum Levels of Glial Biomarkers, Clinical Severity and Electro-encephalography Features in Idiopathic West and Lennox-Gastaut Syndromes

Charkazzade M., Soylu S., Tüzün E., Yılmaz V., Sezgin M., Yapıcı Z., et al.

NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , vol.61, no.2, pp.128-134, 2024 (SCI-Expanded)

Electrodiagnostic methods to verify Guillain-Barré syndrome subtypes in Istanbul: A prospective multicenter study

Tasdemir V., Sirin N. G., Cakar A., Culha A., Soysal A., Elmali A. D., et al.

JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM , vol.29, no.1, pp.72-81, 2024 (SCI-Expanded) Sustainable Development

Autoimmune Encephalitis with Antibodies Against A-Amino-3hydroxy-5-Methyl-4-Isoxazolepropionic Acid Receptor and γ-Aminobutyric Acid-Beta Receptor: Case Report

Doğan F. U., Samanci B., YILMAZ V., Hanağasi H. A., Gürvit İ. H., TÜZÜN E., et al.

Noropsikiyatri Arsivi , vol.61, no.1, pp.94-96, 2024 (SCI-Expanded)

Peripheral blood regulatory B and T cells are decreased in patients with focal epilepsy

ŞANLI E., ŞİRİN İNAN N. G., KÜÇÜKALİ C. İ., Baykan B., ULUSOY C. A., BEBEK N., et al.

JOURNAL OF NEUROIMMUNOLOGY , vol.387, 2024 (SCI-Expanded)

Seronegative NMOSD patients display distinctive peripheral blood T-cell subset frequencies

Sanli E., Karaaslan Z., Yilmaz V., Gunduz T., Kurtuncu M., Turkoglu R., et al.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY , 2024 (SCI-Expanded) Sustainable Development

Disease activity in chronic inflammatory demyelinating polyneuropathy: association between circulating B-cell subsets, cytokine levels, and clinical outcomes

Ozdag Acarli A. N., Tuzun E., Sanli E., Koral G., Akbayir E., Cakar A., et al.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY , vol.215, no.1, pp.65-78, 2024 (SCI-Expanded) Sustainable Development

Silencing of FCRLB by shRNA ameliorates MuSK-induced EAMG in mice

Koral G., Ulusoy C., Cossins J., Lazaridis K., Türkoğlu R., Dong Y. Y., et al.

JOURNAL OF NEUROIMMUNOLOGY , vol.383, 2023 (SCI-Expanded)

Chloride intracellular channel protein-1 (CLIC1) antibody in multiple sclerosis patients with predominant optic nerve and spinal cord involvement

KARAASLAN Z., Şengül-Yediel B., Yüceer-Korkmaz H., ŞANLI E., GEZEN AK D., DURSUN E., et al.

MULTIPLE SCLEROSIS AND RELATED DISORDERS , vol.78, 2023 (SCI-Expanded)

Distribution of peripheral blood mononuclear cell subtypes in patients with West syndrome: Impact of synacthen treatment

Soylu S., Cherkezzade M., Akbayır E., Korkmaz H., Koral G., Şanlı E., et al.

IMMUNOLOGY LETTERS , vol.261, pp.17-24, 2023 (SCI-Expanded)

Therapeutic Effect of C-Vx Substance in K18-hACE2 Transgenic Mice Infected with SARS-CoV-2

Ulbegi Polat H., Abaci I., Tas Ekiz A., Aksoy O., ÖKTELİK F. B., YILMAZ V., et al.

International Journal of Molecular Sciences , vol.24, no.15, 2023 (SCI-Expanded)

Autoimmune Mechanisms in Focal Epilepsy of Unknown Cause

ŞANLI E., YILMAZ V., TÜZÜN E.

NEUROLOGICAL SCIENCES AND NEUROPHYSIOLOGY , vol.40, no.3, pp.113-121, 2023 (SCI-Expanded)

Ocrelizumab Treatment Modulates B-Cell Regulating Factors in Multiple Sclerosis

Ho S., Oswald E., Wong H. K., Vural A., Yilmaz V., Tüzün E., et al.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION , vol.10, no.2, 2023 (SCI-Expanded)

Elevated sTREM2 and NFL levels in patients with sepsis associated encephalopathy

ORHUN G., ESEN F., YILMAZ V., Ulusoy C., ŞANLI E., Yildirim E., et al.

INTERNATIONAL JOURNAL OF NEUROSCIENCE , vol.133, no.3, pp.327-333, 2023 (SCI-Expanded)

The modulatory action of C-Vx substance on the immune system in COVID-19

Tahrali I., Akdeniz N., Yilmaz V., Kucuksezer U. C., Oktelik F. B., Ozdemir O., et al.

EMERGING MICROBES & INFECTIONS , vol.11, no.1, pp.2698-2710, 2022 (SCI-Expanded)

Serum 3-phenyllactic acid level is reduced in benign multiple sclerosis and is associated with effector B cell ratios

Oezguen N., Yılmaz V., Horvath T. D., Akbayir E., Haidacher S. J., Hoch K. M., et al.

MULTIPLE SCLEROSIS AND RELATED DISORDERS , vol.68, 2022 (SCI-Expanded)

Sex-specific analysis in Behcet's disease reveals higher genetic risk in male patients

Jo Y. G., Ortiz-Fernandez L., Coit P., Yilmaz V., Yentur S. P., ALİBAZ ÖNER F., et al.

JOURNAL OF AUTOIMMUNITY , vol.132, 2022 (SCI-Expanded)

Immune modulation as a consequence of SARS-CoV-2 infection

Gelmez M. Y., Öktelik F. B., Tahralı İ., Yılmaz V., Küçüksezer U. C., Akdeniz N., et al.

FRONTIERS IN IMMUNOLOGY , vol.13, 2022 (SCI-Expanded)

Classical complement pathway factor alterations in narcolepsy.

Yüceer H., Gezen Ak D., Benbir Şenel G., Dursun E., Yilmaz V., Karadeniz D., et al.

Acta neuropsychiatrica , vol.34, no.4, pp.212-219, 2022 (SCI-Expanded) Sustainable Development

IgG4 Autoantibodies in Organ-Specific Autoimmunopathies: Reviewing Class Switching, Antibody-Producing Cells, and Specific Immunotherapies.

Koneczny I., Tzartos J., Mané-Damas M., Yilmaz V., Huijbers M. G., Lazaridis K., et al.

Frontiers in immunology , vol.13, no.13, pp.834342, 2022 (SCI-Expanded)

Fingolimod impairs inactivated vaccine (CoronaVac)-induced antibody response to SARS-CoV-2 spike protein in persons with multiple sclerosis.

Türkoğlu R., Baliç N., Kızılay T., Erol R., Akbayır E., Yılmaz V., et al.

Multiple sclerosis and related disorders , vol.58, pp.103524, 2022 (SCI-Expanded)

CXCL13 Levels Indicate Treatment Responsiveness to Fingolimod in MS Patients

KARAASLAN Z., KÜRTÜNCÜ M., Akcay H. I., GÜNDÜZ T., Altunrende B., Turkoglu R., et al.

EUROPEAN NEUROLOGY , vol.85, no.1, pp.69-71, 2022 (SCI-Expanded)

Cerebrospinal fluid level of neurofilament light chain is associated with increased disease activity in neuro-Behcet's disease

Karaaslan Z., Şanlı E., Timirci-Kahraman Ö., Yılmaz V., Akbayır E., Koral G., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , vol.52, no.4, pp.1266-1273, 2022 (SCI-Expanded)

Decline of humoral immune responses after natural SARS-CoV-2 infection can be efficiently reversed by vaccination

Oktelik F. B., Yilmaz V., Gelmez M. Y., Akdeniz N., Pamukcu C., Sutlu T., et al.

CANADIAN JOURNAL OF MICROBIOLOGY , vol.68, pp.543-550, 2022 (SCI-Expanded)

Expression of Akt1 and p-Akt1 in peripheral T cell subsets of multiple sclerosis patients.

Oktelik F. B., Yilmaz V., Turkoglu R., Akbayir E., Tuzun E., Deniz G., et al.

Acta neurologica Belgica , vol.121, no.6, pp.1777-1782, 2021 (SCI-Expanded)

miR-132-3p, miR-106b-5p, and miR-19b-3p Are Associated with Brain-Derived Neurotrophic Factor Production and Clinical Activity in Multiple Sclerosis: A Pilot Study

SAĞIR F., Tunali N. E., TOMBUL T., Koral G., Cirak S., YILMAZ V., et al.

GENETIC TESTING AND MOLECULAR BIOMARKERS , no.11, pp.720-726, 2021 (SCI-Expanded) Sustainable Development

Cerebrospinal fluid level of phosphorylated neurofilament heavy chain is higher in converting clinically isolated syndrome and correlates with CAMP response element-binding protein concentration

Gencer M., Koral G., ŞANLI E., Cirak S., Akbayir E., YÜCEER H., et al.

Neurological Sciences and Neurophysiology , vol.38, no.4, pp.256-261, 2021 (SCI-Expanded)

Effects of Teriflunomide on B Cell Subsets in MuSK-Induced Experimental Autoimmune Myasthenia Gravis and Multiple Sclerosis

YILMAZ V., Ulusoy C., Hajtovic S., Turkoglu R., Kurtuncu M., Tzartos J., et al.

Immunological Investigations , vol.50, pp.671-684, 2021 (SCI-Expanded)

Peripheral blood B cell subset ratios and expression levels of B cell-associated genes are altered in benign multiple sclerosis

Turkoglu R., YILMAZ V., ÖZDEMİR Ö., Akbayir E., Benbir G., Arsoy E., et al.

MULTIPLE SCLEROSIS AND RELATED DISORDERS , vol.52, 2021 (SCI-Expanded)

Genetic Association of a Gain-of-Function IFNGR1 Polymorphism and the Intergenic Region LNCAROD/DKK1 With Behcet's Disease

Ortiz Fernández L., Coit P., Yilmaz V., Yentür S. P., Alibaz-Oner F., Aksu K., et al.

ARTHRITIS & RHEUMATOLOGY , vol.73, no.7, pp.1244-1252, 2021 (SCI-Expanded)

Impact of Autoimmune Demyelinating Brain Disease Sera on Pericyte Survival

Ulusoy C., Şekerdağ E., YILMAZ V., Yilmaz A. B., Atak D., Vural A., et al.

NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , no.2, pp.83-86, 2021 (SCI-Expanded)

Adaptive immunity cells are differentially distributed in the peripheral blood of glycine receptor antibody-positive patients with focal epilepsy of unknown cause.

Sanli E., Akbayir E., Kuçukali C. İ., Baykan B., Sirin N. G., Bebek N., et al.

Epilepsy research , vol.170, pp.106542, 2021 (SCI-Expanded)

CSF levels of HoxB3 and YKL-40 may predict conversion from clinically isolated syndrome to relapsing remitting multiple sclerosis.

Tamam Y., Gunes B., Akbayir E., Kizilay T., Karaaslan Z., Koral G., et al.

Multiple sclerosis and related disorders , vol.48, no.1, pp.102697, 2021 (SCI-Expanded)

Inflammation and regulatory T cell genes are differentially expressed in peripheral blood mononuclear cells of Parkinson's disease patients.

Karaaslan Z., Kahraman Ö. T., Şanlı E., Ergen H. A., Ulusoy C., Bilgiç B., et al.

Scientific reports , vol.11, no.1, pp.2316, 2021 (SCI-Expanded) Sustainable Development

Common Denominators in the Immunobiology of IgG4 Autoimmune Diseases: What Do Glomerulonephritis, Pemphigus Vulgaris, Myasthenia Gravis, Thrombotic Thrombocytopenic Purpura and Autoimmune Encephalitis Have in Common?

Koneczny I., YILMAZ V., Lazaridis K., Tzartos J., Lenz T. L., Tzartos S., et al.

FRONTIERS IN IMMUNOLOGY , vol.11, 2021 (SCI-Expanded)

Serum antiganglioside antibodies in patients with autoimmune limbic encephalitis

Culha Oktar A., Selcuk O., Elmas Tunc C., IŞILDAK Ş., ŞANLI E., YILMAZ V., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , vol.51, no.5, pp.2570-2574, 2021 (SCI-Expanded)

The treatment effect on peripheral B cell markers in antibody positive myasthenia gravis patients

YILMAZ V., TÜZÜN E., DURMUŞ TEKÇE H., Oflazer P., Aysal F., Parman Y., et al.

JOURNAL OF NEUROIMMUNOLOGY , vol.349, 2020 (SCI-Expanded)

Comparison of Circulating Levels of Uremic Toxins in Hemodialysis Patients Treated with Medium Cut-Off Membranes and High-Flux Membranes: Theranova in Sisli Hamidiye Etfal (THE SHE) Randomized Control Study

Sevinc M., Hasbal N. B., Yilmaz V., Basturk T., Ahbap E., Sakaci T., et al.

BLOOD PURIFICATION , no.6, pp.733-742, 2020 (SCI-Expanded) Sustainable Development

Peripheral blood expression levels of inflammasome complex components in two different focal epilepsy syndromes

Ulusoy C., Vanlı-Yavuz E., Şanlı E., Timirci-Kahraman Ö., Yılmaz V., Bebek N., et al.

Journal of Neuroimmunology , vol.347, 2020 (SCI-Expanded)

Late-onset generalized myasthenia gravis: clinical features, treatment, and outcome

Yildiz Celik S., DURMUŞ TEKÇE H., YILMAZ V., SARUHAN DİRESKENELİ G., Gulsen Parman Y., Serdaroglu Oflazer P., et al.

ACTA NEUROLOGICA BELGICA , vol.120, no.1, pp.133-140, 2020 (SCI-Expanded)

Sleep disturbance and cognitive decline in multiple sclerosis patients with isolated optic neuritis as the first demyelinating event

Türkoğlu R., Benbir G., Özyurt S., Arsoy E., Akbayır E., Turan S., et al.

International Ophthalmology , vol.40, no.1, pp.151-158, 2020 (SCI-Expanded)

Impact of fingolimod on CD4+T cell subset and cytokine profile of relapsing remitting multiple sclerosis patients

Kurtuncu M., Yilmaz V., Akcay H. I., Turkoglu R., Altunrende B., Cinar S., et al.

JOURNAL OF NEUROIMMUNOLOGY , vol.337, 2019 (SCI-Expanded)

Cytokine-chemokine and cognitive profile of multiple sclerosis patients with predominant optic nerve and spinal cord involvement

Sen M., Akbayir E., Mercan O., Arsoy E., Gencer M., Yilmaz V., et al.

JOURNAL OF SPINAL CORD MEDICINE , 2019 (SCI-Expanded)

Enhanced NLRP3 and DEFA1B Expression During the Active Stage of Parenchymal Neuro-Behcet's Disease

UGUREL E., ERDAG E., KUCUKALI C. İ., OLCAY A., Sanli E., AKBAYIR E., et al.

IN VIVO , vol.33, no.5, pp.1493-1497, 2019 (SCI-Expanded)

Relation of HLA-DRB1 to IgG4 autoantibody and cytokine production in muscle-specific tyrosine kinase myasthenia gravis (MuSK-MG).

ÇEBI M., DURMUŞ H., YILMAZ V., YENTÜR S. P., AYSAL F., OFLAZER P., et al.

Clinical and experimental immunology , vol.197, pp.214-221, 2019 (SCI-Expanded)

Serum orexin-A levels are associated with disease progression and motor impairment in multiple sclerosis

Gencer M., Akbayir E., Sen M., Arsoy E., Yilmaz V., Bulut N., et al.

NEUROLOGICAL SCIENCES , vol.40, no.5, pp.1067-1070, 2019 (SCI-Expanded)

Acute ophthalmoparesis and persistent mydriasis: expanding the clinical spectrum of anti-GQ1b positive cranial neuropathy in a 5.5-year-old girl

Gunes A. S., Genc H., Yalcin E. U., YILMAZ V., Direskeneli G. S., KARA B.

TURKISH JOURNAL OF PEDIATRICS , vol.61, no.5, pp.794-797, 2019 (SCI-Expanded)

Regulatory B cells in myasthenia gravis are differentially affected by therapies

YILMAZ V., Maillard S., Truffault F., Bolgert F., Behin A., Regnard J., et al.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY , vol.5, no.11, pp.1408-1414, 2018 (SCI-Expanded)

Peripheral blood memory B cell frequency predicts conversion from clinically isolated syndrome to multiple sclerosis

Aktura S. D., Yilmaz V., Ozkan-Yasargun D., Ulusoy C., Tuzun E., Turkoglu R.

MULTIPLE SCLEROSIS AND RELATED DISORDERS , vol.23, pp.9-14, 2018 (SCI-Expanded)

VIABILITY OF SH-SY5Y CELLS IS ASSOCIATED WITH PURINERGIC P2 RECEPTOR EXPRESSION ALTERATIONS

Orcen A., Yilmaz V., Giris M., Akcan U., Tuzun E., Erten G.

ACTA BIOLOGICA HUNGARICA , vol.68, no.1, pp.22-34, 2017 (SCI-Expanded)

Prompt Response to Prednisone Predicts Benign Course in MuSK-MG

Gungor-Tuncer O., Yilmaz V., Toker A., Saruhan-Direskeneli G., Gulsen-Parman Y., Oflazer-Serdaroglu P., et al.

EUROPEAN NEUROLOGY , vol.78, pp.137-142, 2017 (SCI-Expanded)

Immunization with Recombinantly Expressed LRP4 Induces Experimental Autoimmune Myasthenia Gravis in C57BL/6 Mice

Ulusoy C. A., Cavus F., Yilmaz V., Tuzun E.

IMMUNOLOGICAL INVESTIGATIONS , vol.46, no.5, pp.490-499, 2017 (SCI-Expanded) Sustainable Development

Dense Genotyping of Immune Related Loci in a Multi-Ethnic Behcet's Disease Cohort Identifies Genetic Associations in a Long Noncoding RNA Near QSOX2, RASIP1/FUT2, and IL12A-AS1

Renauer P., Coit P., Hughes T., Ognenovski M., Adler A., Ortiz-Fernandez L., et al.

ARTHRITIS & RHEUMATOLOGY , vol.68, 2016 (SCI-Expanded)

Chemokine and Chemokine Receptor Polymorphisms in Bipolar Disorder

Tokaç D., Tuzun E., GULEC H., Yilmaz V., Bireller E. S., Cakmakoglu B., et al.

PSYCHIATRY INVESTIGATION , vol.13, no.5, pp.541-548, 2016 (SCI-Expanded)

Genetic heterogeneity within the HLA region in three distinct clinical subgroups of myasthenia gravis.

Saruhan-Direskeneli G., HUGHES T., Yilmaz V., Durmus H., ADLER A., Alahgholi-Hajibehzad M., et al.

Clinical immunology (Orlando, Fla.) , pp.81-8, 2016 (SCI-Expanded)

cFLIP overexpression in T cells in thymoma-associated myasthenia gravis

BELHARAZEM D., SCHALKE B., GOLD R., NIX W., VITACOLONNA M., HOHENBERGER P., et al.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY , vol.2, no.9, pp.894-905, 2015 (SCI-Expanded)

Differential cytokine changes in patients with myasthenia gravis with antibodies against AChR and MuSK

Yilmaz V., Oflazer P., AYSAL F., Durmus H., Poulas K., Yentur S. P., et al.

PLoS ONE , vol.10, no.4, 2015 (SCI-Expanded)

Activation of the JAK/STAT pathway in Behcet's disease

Tulunay A., DOZMOROV M. G., Ture-Ozdemir F., Yilmaz V., Eksioglu-Demiralp E., Alibaz-Oner F., et al.

GENES AND IMMUNITY , vol.16, no.2, pp.170-175, 2015 (SCI-Expanded) Sustainable Development

B cells produce less IL-10, IL-6 and TNF-α in myasthenia gravis

Yilmaz V., Oflazer P., AYSAL F., Parman Y. G., Direskeneli H., Deymeer F., et al.

Autoimmunity , vol.48, no.4, pp.201-207, 2015 (SCI-Expanded)

The association of PTPN22 R620W polymorphism is stronger with late-onset AChR-myasthenia gravis in Turkey

Kaya G., Coskun A. N., Yilmaz V., Oflazer P., Gulsen-Parman Y., AYSAL F., et al.

PLoS ONE , vol.9, no.8, 2014 (SCI-Expanded)

Preferential production of IgG1, IL-4 and IL-10 in MuSK-immunized mice

Ulusoy C. A., KIM E., Tuzun E., HUDA R., Yilmaz V., Poulas K., et al.

Clinical Immunology , vol.151, no.2, pp.155-163, 2014 (SCI-Expanded) Sustainable Development

Prepubertal anti-Musk positive myasthenia gravis with long remission

Gungor-Tuncer O., Orhan E., Yilmaz V., Parman Y., Oflazer P., Saruhan-Direskeneli G., et al.

Neuromuscular Disorders , vol.24, no.1, pp.36-39, 2014 (SCI-Expanded)

**Association of HLA-DRB114, -DRB116 and -DQB1*05 with MuSK-myasthenia gravis in patients from Turkey**

Alahgholi-Hajibehzad M., Yilmaz V., Gulsen-Parman Y., Aysal F., Oflazer P., Deymeer F., et al.

Human Immunology , vol.74, no.12, pp.1633-1635, 2013 (SCI-Expanded)

Identification of multiple independent susceptibility loci in the HLA region in Behçet's disease

HUGHES T., COIT P., ADLER A., Yilmaz V., AKSU K., Duzgun N., et al.

Nature Genetics , vol.45, no.3, pp.319-324, 2013 (SCI-Expanded) Sustainable Development

Aquaporin-4 antibody seropositivity in myasthenia gravis patients with thymoma

Ekizoglu E., Yilmaz V., Icoz S., Birisik O., Tuzun E., Akman-Demir G., et al.

Muscle and Nerve , vol.47, no.2, pp.306-307, 2013 (SCI-Expanded)

**Takayasu's arteritis is associated with HLA-B52, but not with HLA-B51, in Turkey.**

Sahin Z., Bicakcigil M., AKSU K., Kamali S., Akar S., Onen F., et al.

Arthritis research & therapy , vol.14, no.1, 2012 (SCI-Expanded) Sustainable Development

A putative functional variant within the UBAC2 gene is associated with increased risk of Behçet's disease

SAWALHA A. H., HUGHES T., NADIG A., Yilmaz V., AKSU K., KESER G., et al.

Arthritis and Rheumatism , vol.63, no.11, pp.3607-3612, 2011 (SCI-Expanded)

Increased complement consumption in musk-antibody-positive myasthenia gravis patients

Tuzun E., Yilmaz V., Parman Y., Oflazer P., Deymee F., Saruhan-Direskeneli G.

Medical Principles and Practice , vol.20, no.6, pp.581-583, 2011 (SCI-Expanded)

COMMON VARIANTS WITHIN THE UBAC2 GENE ARE ASSOCIATED WITH INCREASED RISK OF BEHCET'S DISEASE

Sawalha A., Hughes T., Nadig A., Yilmaz V., AKSU K., KESER G., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.28, no.4, 2010 (SCI-Expanded)

EXPRESSION OF TRANSCRIPTION FACTORS OF CD4+T HELPER CELLS IN BEHCET'S DISEASE

Parlakgul G., Yilmaz V., Guney E., Guner H. A., Erer B., Direskeneli H., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.28, no.4, 2010 (SCI-Expanded)

IDENTIFICATION OF JAK1 AS A CANDIDATE INFLAMMATORY SIGNALLING PATHWAY BY GENOME-WIDE EXPRESSION PROFILING IN MONOCYTES FROM PATIENTS WITH BEHCET'S DISEASE

Direskeneli H., Boyle J., Ozdemir F., Yilmaz V., Eksioglu-Demiralp E., Haskard D., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , no.4, 2010 (SCI-Expanded)

Long Remission in Muscle-Specific Kinase Antibody-Positive Juvenile Myasthenia

Anlar B., Yilmaz V., Saruhan-Direskeneli G.

PEDIATRIC NEUROLOGY , vol.40, no.6, pp.455-456, 2009 (SCI-Expanded)

Mannose-binding lectin pathway is not involved in myasthenia gravis pathogenesis

LI J., QI H., Tuzun E., ALLMAN W., Yilmaz V., SAINI S. S., et al.

Journal of Neuroimmunology , vol.208, pp.40-45, 2009 (SCI-Expanded)

B cell regulating activity in patients with myasthenia gravis

Yilmaz V., Oflazer P., Parman Y., Deymeer F., Saruhan-Direskeneli G.

JOURNAL OF NEUROIMMUNOLOGY , vol.203, no.2, pp.179, 2008 (SCI-Expanded)

The role of HLA-DRB1 shared epitope alleles in predicting short-term response to leflunomide in rheumatoid arthritis

SARUHAN-DIRESKENELI G., INANC M., FRESKO I., AKKOC N., DALKILIC E., ERKEN E., et al.

Rheumatology , vol.46, no.12, pp.1842-1844, 2007 (SCI-Expanded)

Interleukin (IL)-12, IL-2, interferon-γ gene polymorphisms in subacute sclerosing panencephalitis patients

Yilmaz V., Demirbilek V., Gurses C., Yentur S. P., Uysal S., Yapici Z., et al.

Journal of NeuroVirology , vol.13, no.5, pp.410-415, 2007 (SCI-Expanded) Sustainable Development

Polymorphisms of interferon-γ, interleukin-10, and interleukin-12 genes in myasthenia gravis

Yilmaz V., Tutuncu Y., HASBAL N. B., Parman Y., SERDAROGLU P., Deymeer F., et al.

Human Immunology , vol.68, no.6, pp.544-549, 2007 (SCI-Expanded)

Clinical comparison of anti-MuSK- vs anti-AChR-positive and seronegative myasthenia gravis

Deymeer F., GUNGOR-TUNCER O., Yilmaz V., Parman Y., SERDAROGLU P., OZDEMIR C., et al.

Neurology , vol.68, no.8, pp.609-611, 2007 (SCI-Expanded)

Interleukin (IL)-12, IL-2, and IL-6 gene polymorphisms in Takayasu's arteritis from Turkey

Saruhan-Direskeneli G., BICAKCIGIL M., Yilmaz V., Kamali S., AKSU K. I., FRESKO I., et al.

HUMAN IMMUNOLOGY , vol.67, no.9, pp.735-740, 2006 (SCI-Expanded)

IL-12 and IL-10 polymorphisms and their effects on cytokine production

Yilmaz V., YENTUR S. P., SARUHAN-DIRESKENELI G.

Cytokine , vol.30, no.4, pp.188-194, 2005 (SCI-Expanded)

Polymorphisms of the IL-8 and CXCR2 genes are not associated with Behcet's disease

Duymaz-Tozkir J., Yilmaz V., Uyar F., Hajeer A., Saruhan-Direskeneli G., Gul A.

JOURNAL OF RHEUMATOLOGY , vol.32, no.1, pp.93-97, 2005 (SCI-Expanded)

Natural killer cell activity in multidrug-resistant pulmonary tuberculosis

YILDIZ P., KADAKAL F., Tutuncu Y., DENIZ G., Gurel N. S., Adin S., et al.

RESPIRATION , vol.68, no.6, pp.590-594, 2001 (SCI-Expanded) Sustainable Development

Articles Published in Other Journals

Serum CXCL5 as a biomarker in multiple sclerosis and neuromyelitis optica spectrum disorder

KARAASLAN Z., YILMAZ V., YÜCEER H., ŞANLI E., Akcay H. I., Kurtuncu M., et al.

Northern Clinics of Istanbul , vol.10, no.3, pp.341-344, 2023 (ESCI)

The psychocognitive, biochemical, and electrophysiological effects of cerebral ischemia-reperfusion injury in patients undergoing carotid endarterectomy accompanied by cervical block

Canbay Sarılar Ç., Arslanoğlu E., Kara K. A., Bakhshaliyev S., Altunyuva K., Yılmaz V., et al.

Turkish journal of vascular surgery , vol.30, no.3, pp.229-235, 2021 (Peer-Reviewed Journal)

Intracytoplasmic and Plasma Cytokine Levels of Natural Killer Cells in Patients with Asthma

AKDENİZ N., ÇETİN E., Yurdagul G. E., YILMAZ V., Gemicioglu B., DENİZ G.

TURKISH JOURNAL OF IMMUNOLOGY , vol.9, no.2, pp.86-94, 2021 (ESCI)

The effect of cognitive rehabilitation on peripheral blood B cell distribution and specific gene expression levels in MS patients

Akbayır E., Şen M., Arsoy E., Türkoğlu R., Yılmaz V., Tüzün E.

Journal of Multiple Sclerosis Research , vol.1, no.2, pp.32-39, 2021 (Peer-Reviewed Journal)

Evaluation of Patients with Suspicion of COVID-19 in Pediatric Emergency Department

Alp E. E., Dalgic N., Yilmaz V., Altuntas Y., Ozdemir H. M.

MEDICAL BULLETIN OF SISLI ETFAL HOSPITAL , vol.55, no.2, pp.179-187, 2021 (ESCI) Sustainable Development

A Case of HaNDL with Low Cerebrospinal Fluid Level of Neurofilament Light Chain

Sisman A. B., Bayar M. D., İçöz S., YILMAZ V., Kürtüncü M., TÜZÜN E., et al.

Case Reports in Neurology , vol.12, no.3, pp.334-338, 2020 (ESCI)

B Cell Immunophenotyping and Expression Analysis of B Cell Specific Molecules of Patients with Benign Multiple Sclerosis

Akbayır E., Şen M., Türkoğlu R., TÜZÜN E., YILMAZ V.

Experimed , vol.9, no.3, pp.105-112, 2019 (Peer-Reviewed Journal)

Expression Levels of Inflammasome Complexes in Experimental Autoimmune Myasthenia Gravis Mouse Model (EAMG).

Baltacı C. N., YILMAZ V., ULUSOY C. A., TÜZÜN E., VURAL B.

Experimed , vol.9, no.3, pp.79-85, 2019 (Peer-Reviewed Journal)

Expression levels of inflammasome complexes in experimental autoimmune myasthenia gravis mouse model (EAMG)

Baltacı C., Yılmaz V., Ulusoy C. A., Tüzün E., Vural B.

EXPERIMED , vol.9, no.3, pp.79-85, 2019 (Peer-Reviewed Journal)

B cell immunophenotyping and expression analysis of B cell specific molecules of patients with benign multiple sclerosis

Şen M., Akbayır E., Türkoğlu R., Tüzün E., Yılmaz V.

EXPERIMED , vol.9, no.3, pp.105-112, 2019 (Peer-Reviewed Journal)

Flow Cytometry Analysis of Peripheral Blood B Cell Distribution of Patients with Multiple Sclerosis

Yilmaz V., Tura D. A., Ulusoy C., Yasargun D. O., Cinar S., Turkoglu R.

TURKISH JOURNAL OF NEUROLOGY , vol.23, no.4, pp.219-224, 2017 (ESCI)

Peripheral Blood Cell Immunophenotypes in Multiple Sclerosis Patients in Remission

YILMAZ V., ULUSOY C. A., MERCAN Ö., ÇINAR S., TÜRKOĞLU R.

Haydarpasa Numune Training and Research Hospital Medical Journal , vol.57, pp.101-103, 2017 (Peer-Reviewed Journal)

Refereed Congress / Symposium Publications in Proceedings